Molecular and Functional Assessment of TSC1 and TSC2 in Individuals with Tuberous Sclerosis Complex

Tuberous sclerosis complex (TSC) is an autosomal dominant neurodevelopmental disorder and multisystem disease caused by pathogenic DNA alterations in the <i>TSC1</i> and <i>TSC2</i> tumor suppressor genes. A molecular genetic diagnosis of TSC confirms the clinical diagnosis, facilitating the implementation of appropriate care and surveillance. <i>TSC1</i> and <i>TSC2</i> encode the core components of the TSC1/2 complex (TSC1/2), a negative regulator of the mechanistic target of rapamycin (MTOR) complex 1 (TORC1). Functional analysis of the effects of <i>TSC1</i> and <i>TSC2</i> variants on TORC1 activity can help establish variant pathogenicity. We searched for pathogenic alterations to <i>TSC1</i> and <i>TSC2</i> in DNA isolated from 116 individuals with a definite clinical diagnosis of TSC. Missense variants and in-frame deletions were functionally assessed. Pathogenic DNA alterations were identified in 106 cases (91%); 18 (17%) in <i>TSC1</i> and 88 (83%) in <i>TSC2</i>. Of these, 35 were novel. Disruption of TSC1/2 activity was demonstrated for seven <i>TSC2</i> variants. Molecular diagnostics confirms the clinical diagnosis of TSC in a large proportion of cases. Functional assessment can help establish variant pathogenicity and is a useful adjunct to DNA analysis.

Authors

Institutions

Publication Details

Journal
Genes
Published
2024-11-03
DOI
https://doi.org/10.3390/genes15111432
Citations
3
Primary Topic
Tuberous Sclerosis Complex Research
Type
article
Field-Weighted Citation Impact
0.98

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular and Functional Assessment of TSC1 and TSC2 in Individuals with Tuberous Sclerosis Complex

Ana Paula Aparecida Pereira, Mark Nellist, Laís Faria Masulk Cardozo, Maria Rita Passos‐Bueno et al.
3 citations
Genes
Tuberous Sclerosis Complex Research
0.98
article

Molecular and Functional Assessment of TSC1 and TSC2 in Individuals with Tuberous Sclerosis Complex

Ana Paula Aparecida Pereira, Mark Nellist, Laís Faria Masulk Cardozo, Maria Rita Passos‐Bueno, Santoesha Nanhoe, Juliana Paula Gomes de Almeida, Mariana Richartz Schwind, Sérgio Antônio Antoniuk, Luiz Gustavo Dufner‐Almeida, Andréa Maria Cappellano, Thiago Gerônimo Pires Alegria, Silvana Chiavegatto, Danielly Carvalho, Luciana Amaral Haddad, Nasjla S Silva, Sérgio Rosemberg
article en
3 citations

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant neurodevelopmental disorder and multisystem disease caused by pathogenic DNA alterations in the <i>TSC1</i> and <i>TSC2</i> tumor suppressor genes. A molecular genetic diagnosis of TSC confirms the clinical diagnosis, facilitating the implementation of appropriate care and surveillance. <i>TSC1</i> and <i>TSC2</i> encode the core components of the TSC1/2 complex (TSC1/2), a negative regulator of the mechanistic target of rapamycin (MTOR) complex 1 (TORC1). Functional analysis of the effects of <i>TSC1</i> and <i>TSC2</i> variants on TORC1 activity can help establish variant pathogenicity. We searched for pathogenic alterations to <i>TSC1</i> and <i>TSC2</i> in DNA isolated from 116 individuals with a definite clinical diagnosis of TSC. Missense variants and in-frame deletions were functionally assessed. Pathogenic DNA alterations were identified in 106 cases (91%); 18 (17%) in <i>TSC1</i> and 88 (83%) in <i>TSC2</i>. Of these, 35 were novel. Disruption of TSC1/2 activity was demonstrated for seven <i>TSC2</i> variants. Molecular diagnostics confirms the clinical diagnosis of TSC in a large proportion of cases. Functional assessment can help establish variant pathogenicity and is a useful adjunct to DNA analysis.

GenesVol. 15(11)
Universidade de São Paulo (BR), Erasmus MC (NL), Irmandade da Santa Casa de Misericórdia de São Paulo (BR), Support group for adolescents and children with cancer (BR), Hospital de Clínicas Universidade Federal do Paraná (BR), Universidade Federal do Paraná (BR), Universidade Federal de São Paulo (BR)
Tuberous Sclerosis Alliance
Good health and well-being
Openalex Percentile: Top 23%
Tuberous Sclerosis Complex Research
0.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.